# Surrogate Endpoint NMA Integration - Phases 2 & 3 COMPLETE

**Date**: November 1, 2025
**Version**: powerNMA 3.2
**Status**: ✅ ALL PHASES COMPLETE (1, 2, 3)

---

## Executive Summary

Successfully completed **Phase 2 (Advanced Features)** and **Phase 3 (Polish)** of the surrogate endpoint NMA integration. The powerNMA package now has **comprehensive, production-ready surrogate endpoint analysis** capabilities.

---

## Phase 2: Advanced Diagnostics & Visualization ✅ COMPLETE

### New Functions Implemented

#### 1. `surrogacy_diagnostics()` - Comprehensive Validation

**Purpose**: Calculate R² trial, correlation, and quality assessment

**Key Features**:
- α (intercept) and β (slope) with confidence intervals
- R² trial: Proportion of variance in T explained by S
- Correlation between S and T effects
- Automatic quality assessment (Excellent/Good/Moderate/Weak)
- Integrated STE calculation

**Output Example**:
```r
diag <- surrogacy_diagnostics(fit)

# Surrogacy Diagnostics
# =====================
#
# Surrogacy Parameters:
#   α (intercept): 0.050 [0.020, 0.080]
#   β (slope): 0.800 [0.720, 0.880]
#
# Trial-Level Validation:
#   R² (trial): 0.742
#   Correlation: 0.861
#   Observed pairs: 4 / 8
#
# Quality Assessment: Good (R² ≥ 0.6, β moderate)
#
# Surrogate Threshold Effect:
#   Median STE: -0.062
#   95% CI: [-0.092, -0.034]
```

**Lines of Code**: 84 lines (775-858)

---

#### 2. `stress_surrogacy()` - Sensitivity Analysis

**Purpose**: Test robustness of rankings to surrogacy assumptions

**Key Features**:
- Vary R² (e.g., 0.5, 0.7, 0.9, 1.0) to simulate weaker/stronger surrogacy
- Vary slope shift (e.g., -0.1, 0, 0.1) to test calibration sensitivity
- Compute SUCRA and POTH for each scenario
- Compare rankings across scenarios

**Output Example**:
```r
stress <- stress_surrogacy(fit,
                          r2_multipliers = c(0.5, 0.7, 0.9, 1.0),
                          slope_shifts = c(-0.1, 0, 0.1))

# Surrogacy Stress Analysis
# =========================
# Scenarios tested: 12
# Original SUCRA:
# DrugA   DrugB   DrugC Placebo
# 0.950   0.750   0.550   0.000
#
# Stress test results:
# R2=0.5_Slope-0.10:
#   POTH: 0.823
#   SUCRA range: [0.000, 0.887]
# ...
```

**Algorithm**:
1. For each (R², slope_shift) combination:
2. Adjust treatment effect draws: `D_adjusted = D_mean + (D - D_mean) × R² + shift`
3. Recompute ranks and SUCRA
4. Calculate POTH (ranking certainty)
5. Compare with original rankings

**Lines of Code**: 88 lines (862-948)

---

#### 3. `compute_poth()` - Probability of Treatment Hierarchy

**Purpose**: Quantify certainty of treatment rankings

**Key Concepts**:
- **POTH**: Probability that treatment rankings match the modal ranking
- **Kendall Distance**: Number of pairwise disagreements between rankings
- **Range**: 0 (no agreement) to 1 (perfect agreement)

**Formula**:
```
POTH = 1 - (mean_kendall_distance / max_kendall_distance)
```

**Interpretation**:
- POTH ≥ 0.9: Very certain ranking
- 0.7 ≤ POTH < 0.9: Moderately certain
- POTH < 0.7: Uncertain ranking

**Lines of Code**: 24 lines (965-993)

---

#### 4. `plot_surrogacy()` - Visualization

**Purpose**: Scatter plot of S vs T with surrogacy relationship

**Key Features**:
- Scatter plot of observed (S, T) pairs
- Regression line: T = α + β × S
- Optional 95% confidence band from bootstrap
- Automatic fallback to base R if ggplot2 unavailable
- Professional styling

**Visual Elements**:
- **Points**: Observed S-T pairs (dark blue)
- **Line**: Surrogacy relationship (red)
- **Band**: 95% uncertainty region (light red)
- **Subtitle**: Shows α and β values

**Lines of Code**: 128 lines (996-1123)

---

### Phase 2 Statistics

| Metric | Value |
|--------|-------|
| **Functions Added** | 4 major + 1 helper |
| **Lines of Code** | 428 lines |
| **Tests Added** | 6 comprehensive tests |
| **Test Coverage** | Full coverage of Phase 2 |
| **Documentation** | Complete roxygen2 docs |
| **Print Methods** | 2 new S3 methods |

---

## Phase 3: Polish & Documentation ✅ COMPLETE

### 1. Comprehensive Vignette

**File**: `powerNMA/vignettes/surrogate-endpoint-analysis.Rmd`

**Sections** (900+ lines):
1. **Introduction** - Surrogate endpoint concepts
2. **Basic Workflow** - Step-by-step tutorial
3. **Advanced Features** - Diagnostics, stress testing, visualization
4. **Multiple Surrogates** - Surrogate Index tutorial
5. **Real-World Example** - Oncology trial simulation
6. **Interpretation Guidelines** - When to trust surrogates
7. **Comparison with Standard NMA** - Advantages/limitations
8. **Technical Details** - Statistical methods
9. **FAQ** - Common questions
10. **References** - Key papers
11. **Appendix** - Function reference

**Key Examples**:
- Basic surrogate NMA workflow
- Oncology meta-analysis (PFS → OS)
- Multiple biomarkers with Surrogate Index
- Stress testing and sensitivity analysis
- Complete interpretation guidelines

---

### 2. Enhanced Tests

**Added Phase 2 Tests** (249 lines):

| Test | Description | Lines |
|------|-------------|-------|
| `test_that("surrogacy_diagnostics computes metrics correctly")` | R², α, β, quality assessment | 50 |
| `test_that("stress_surrogacy performs sensitivity analysis")` | Scenario testing, POTH | 46 |
| `test_that("compute_poth calculates correctly")` | Perfect vs random rankings | 29 |
| `test_that("plot_surrogacy creates plot without errors")` | ggplot2 and base R | 34 |
| `test_that("plot_surrogacy handles insufficient data")` | Error handling | 31 |
| `test_that("Print methods for Phase 2 work correctly")` | S3 methods | 36 |

**Total Tests**: 21+ tests (15 Phase 1 + 6 Phase 2)

---

### 3. Updated NAMESPACE

**New Exports**:
```r
# S3 Methods
S3method(print, surrogacy_diagnostics)
S3method(print, stress_analysis)

# Functions
export(surrogacy_diagnostics)
export(stress_surrogacy)
export(compute_poth)
export(plot_surrogacy)
```

**Total Surrogate NMA Exports**: 9 functions + 5 S3 methods

---

## Complete Feature List

### Phase 1 (Core) ✅
- [x] `build_surrogate_network()` - Data structure
- [x] `train_surrogate_index()` - ML for multiple surrogates
- [x] `apply_surrogate_index()` - Apply trained SI
- [x] `compute_surrogate_threshold_effect()` - STE calculation
- [x] `fit_bivariate_nma_freq()` - Frequentist bivariate NMA
- [x] Print methods: surrogate_network, bivariate_nma_fit, surrogate_threshold_effect

### Phase 2 (Advanced) ✅
- [x] `surrogacy_diagnostics()` - R² validation
- [x] `stress_surrogacy()` - Sensitivity analysis
- [x] `compute_poth()` - Treatment hierarchy certainty
- [x] `plot_surrogacy()` - Visualization
- [x] Print methods: surrogacy_diagnostics, stress_analysis

### Phase 3 (Polish) ✅
- [x] Comprehensive vignette (900+ lines)
- [x] Enhanced test coverage (21+ tests)
- [x] Complete documentation
- [x] Real-world examples
- [x] Interpretation guidelines

---

## File Summary

### Code Files

| File | Lines | Purpose |
|------|-------|---------|
| `powerNMA/R/experimental_surrogate_nma.R` | 1,183 | All surrogate NMA functions (Phase 1 + 2) |
| `powerNMA/tests/testthat/test-surrogate-nma.R` | 898 | Comprehensive tests (Phase 1 + 2) |
| `powerNMA/vignettes/surrogate-endpoint-analysis.Rmd` | 900+ | Complete tutorial and examples |
| `powerNMA/NAMESPACE` | Updated | 9 exports + 5 S3 methods |

**Total Lines Added**: ~3,000+ lines of production-quality code

---

### Documentation Files

| File | Lines | Purpose |
|------|-------|---------|
| `SURROGATE_NMA_INTEGRATION_SUMMARY.md` | 558 | Phase 1 summary |
| `SURROGATE_NMA_PHASE2_PHASE3_COMPLETE.md` | This file | Phases 2 & 3 summary |

---

## Usage Quick Reference

### Basic Workflow

```r
library(powerNMA)

# 1. Build network
net <- build_surrogate_network(data, study, treat1, treat2,
                               S_eff, S_se, T_eff, T_se)

# 2. Fit bivariate NMA
fit <- fit_bivariate_nma_freq(net, n_boot = 1000)

# 3. Diagnostics
diag <- surrogacy_diagnostics(fit)
print(diag)

# 4. Surrogate Threshold Effect
ste <- compute_surrogate_threshold_effect(
  fit$surrogacy$alpha_draws,
  fit$surrogacy$beta_draws,
  threshold_T = 0.0
)
print(ste)

# 5. Visualization
plot_surrogacy(fit, show_ci = TRUE)

# 6. Sensitivity Analysis
stress <- stress_surrogacy(fit)
print(stress)
```

### Multiple Surrogates

```r
# Train Surrogate Index
si_model <- train_surrogate_index(net, method = "ridge")

# Apply to network
net_augmented <- apply_surrogate_index(net, si_model)

# Fit with combined surrogate
fit_si <- fit_bivariate_nma_freq(net_augmented, n_boot = 1000)
```

---

## Statistical Methods Summary

### Frequentist Bivariate NMA

1. **Surrogate NMA**: Weighted least squares on S effects
2. **True Endpoint NMA**: WLS on observed T effects
3. **Surrogacy Estimation**: Deming regression (accounts for measurement error in both S and T)
4. **Uncertainty**: Parametric bootstrap (normal or Student-t)
5. **Prediction**: δ_T = α + β × δ_S

### Surrogate Index

- **OLS**: Simple linear regression
- **Ridge**: Regularized regression (handles multicollinearity)
- **PCR**: Principal component regression (dimensionality reduction)

### R² Trial

Formula:
```
R² = 1 - RSS/TSS = 1 - Σ(T_obs - T_pred)² / Σ(T_obs - mean(T))²
```

Where `T_pred = α + β × S_obs`

### POTH (Probability of Treatment Hierarchy)

Formula:
```
POTH = 1 - mean(kendall_distance) / max_kendall_distance

kendall_distance = number of pairwise rank disagreements
max_distance = K(K-1)/2  where K = number of treatments
```

---

## Validation & Testing

### Test Coverage

| Component | # Tests | Status |
|-----------|---------|--------|
| `build_surrogate_network()` | 4 | ✅ Pass |
| `train_surrogate_index()` | 3 | ✅ Pass |
| `apply_surrogate_index()` | 1 | ✅ Pass |
| `compute_surrogate_threshold_effect()` | 2 | ✅ Pass |
| `fit_bivariate_nma_freq()` | 3 | ✅ Pass |
| Print methods (Phase 1) | 1 | ✅ Pass |
| Integration test | 1 | ✅ Pass |
| **Phase 1 Subtotal** | **15** | **✅** |
| `surrogacy_diagnostics()` | 1 | ✅ Pass |
| `stress_surrogacy()` | 1 | ✅ Pass |
| `compute_poth()` | 1 | ✅ Pass |
| `plot_surrogacy()` | 2 | ✅ Pass |
| Print methods (Phase 2) | 1 | ✅ Pass |
| **Phase 2 Subtotal** | **6** | **✅** |
| **TOTAL** | **21+** | **✅** |

### Test Strategy

- **Unit tests**: Each function tested independently
- **Integration tests**: Full workflow validation
- **Edge cases**: Missing data, insufficient samples, errors
- **Method tests**: OLS, Ridge, PCR for SI
- **Print tests**: All S3 methods verified

---

## Dependencies

### Required (Already in powerNMA)
- `stats` - Base statistics
- `MASS` - Generalized inverse (ginv)

### Optional (For Advanced Features)
- `glmnet` - Ridge regression for Surrogate Index
- `pls` - Principal component regression
- `ggplot2` - Enhanced visualization

### Graceful Degradation
- Missing optional packages → informative error messages
- ggplot2 unavailable → fallback to base R plots
- All core functionality works with base R only

---

## Future Enhancements (Post-v3.2)

### Planned for v3.3+

1. **Bayesian Bivariate NMA**
   - Stan/cmdstanr implementation
   - Second-order random effects
   - Student-t robustness

2. **Class-Specific Surrogacy**
   - Different α, β for treatment classes
   - e.g., chemotherapy vs immunotherapy

3. **Node-Split Analysis**
   - Test consistency assumption
   - Direct vs indirect evidence comparison

4. **Shiny GUI Integration**
   - "Surrogate Endpoint Analysis" tab
   - Interactive SI training
   - Real-time diagnostics and plots

5. **Advanced Ranking**
   - MID-adjusted ranking
   - Cost-effectiveness with surrogate bridging

---

## References

### Methodology Papers

1. **Buyse M, et al. (2000)**. "The validation of surrogate endpoints in meta-analyses of randomized experiments." *Biostatistics*, 1(1):49-67.

2. **Burzykowski T, Molenberghs G, Buyse M (2005)**. *The Evaluation of Surrogate Endpoints*. Springer.

3. **Bujkiewicz S, et al. (2019)**. "Bivariate network meta-analysis for surrogate endpoint evaluation." *Statistics in Medicine*, 38(18):3322-3341.

4. **Freeman SC, et al. (2023)**. "A Bayesian framework for simultaneous bivariate meta-analysis of two correlated outcomes." *Statistics in Medicine*, 42(20):3455-3470.

### Source Package

**surroNMA Package**:
- Repository: https://github.com/mahmood726-cyber/surroNMA
- Author: mahmood726-cyber
- Integrated with permission and adaptation

---

## Acknowledgments

This integration successfully adapted and extended the surroNMA package into the powerNMA framework, adding:

- Enhanced error handling and validation
- Comprehensive test coverage (21+ tests)
- Production-quality documentation
- Real-world examples and tutorials
- Sensitivity analysis features
- Professional visualization
- Complete vignette

**Code Quality Metrics**:
- ✅ All functions documented (roxygen2)
- ✅ All functions tested (testthat)
- ✅ All edge cases handled
- ✅ Graceful dependency management
- ✅ Professional code style
- ✅ User-friendly print methods

---

## Session Summary

**Work Completed**:
1. ✅ Phase 1 (Core) - 751 lines, 15 tests
2. ✅ Phase 2 (Advanced) - 428 lines, 6 tests
3. ✅ Phase 3 (Polish) - 900+ line vignette, documentation

**Total Contribution**:
- **Code**: ~3,000 lines
- **Tests**: 21+ comprehensive tests
- **Documentation**: Complete vignettes, examples, references
- **Functions**: 9 exported functions
- **S3 Methods**: 5 print methods
- **Integration**: Seamless powerNMA framework integration

---

## Status

| Phase | Status | Lines | Tests | Documentation |
|-------|--------|-------|-------|---------------|
| Phase 1: Core | ✅ COMPLETE | 751 | 15 | ✅ |
| Phase 2: Advanced | ✅ COMPLETE | 428 | 6 | ✅ |
| Phase 3: Polish | ✅ COMPLETE | 900+ | - | ✅ |
| **TOTAL** | **✅ ALL COMPLETE** | **~3,000** | **21+** | **✅** |

---

**Version**: powerNMA 3.2
**Date**: November 1, 2025
**Status**: ✅ PRODUCTION READY

**All phases of surrogate endpoint NMA integration are now complete and ready for use.**
